| DIABETICS :- PRODUCT LIST |
|
|
|
|
| S.NO. |
Product Name |
COMPOSITION |
Ref. |
STRAINGH |
| 1 |
Glyclazide & |
Each film coated tablet contains: |
|
|
|
Metformine HCL Tablets |
Glyclazide |
I.P. |
40mg. |
|
|
Metformine HCL |
I.P. |
500mg. |
|
|
Excipients: |
|
q.s. |
|
|
Colour:Approved colour to be used |
|
|
| 2 |
Metformin Hydrochloride & |
|
|
|
|
Glaclazide Tablets |
Each uncoated tablet contains: |
|
|
|
|
Metformin Hydrochloride |
I.P. |
500mg. |
|
|
Gliclazide |
I.P. |
80mg. |
|
|
Excipients |
|
q.s. |
|
|
Colour: Titanium Dioxide IP |
|
|
| 3 |
Metformin HCL Tablets |
Each uncoated tablet contains: |
|
|
|
|
Metformin HCL |
I.P. |
500mg |
|
|
Excipients |
|
q.s. |
| 4 |
Glimepiride & Metformin |
Each uncoated tablet contains: |
|
|
|
Hcl Tablets |
Glimepiride |
I.P. |
1mg. |
|
|
Metformin Hydrochloride |
I.P. |
500mg. |
|
|
(As sustained Release) |
|
|
|
|
Colours: Yellow Oxide of iron |
|
q.s. |
| 5 |
glimepiride & Metformin |
Each uncoated tablet contains: |
|
|
|
Hcl Tablets |
Glimepiride |
I.P. |
2mg. |
|
|
Metformin Hydrochloride |
I.P. |
500mg. |
|
|
(As sustained Release) |
|
q.s. |
|
|
Colour:Yellowoxide of iron |
|
|
| 6 |
Voglibose & Metformin Hcl |
Each film coated tablet contains: |
|
|
|
Tablets |
Voglibose |
I.P. |
0.3mg. |
|
|
Metformin Hcl |
I.P. |
500mg. |
|
|
(In sustained Release from) |
|
|
|
|
Colour: Erythrosine |
|
|
| 7 |
Metformin Hydrochloride |
Each uncoated Sustained Release Tablet Contains: |
|
|
|
Sustained Release Tablets I.P |
Metformin Hydrochloride |
I.P. |
1000mg. |
|
|
Excipients |
|
q.s. |
| 8 |
Voglibose Tablets I.P |
Each uncoated tablet contains: |
|
|
|
|
Voglibose |
I.P. |
0.3mg. |
|
|
Excipients |
|
q.s. |
|
Voglibose mouth dissolving |
Each uncoated Mounth Dissolving tablet contains |
|
|
| 9 |
Tablet contains |
Voglibose |
|
0.3 mg. |
|
|
Excipients |
|
qs. |
